|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The Effect of Cannabidiol and URB597 on Conditioned Gaping(a Model of Nausea)Elicited by a Lithium-Paired Context in the Rat显示文摘 | Rock E M Limebeer C L Mechoulam R | 2008 | Psychopharmacology (Berl)2008，196，3： | 1 |
| 2 | The endocannabinoid system and the brain 显示文摘 | Mechoulam R Parker LA | 2013 | Annu Rev Psychol2013，64，： | 1 |
| 3 | Isolation, structure and partial synthesis of an active constituent of hashish 显示文摘 | GAONI Y MECHOULAM R | 1964 | J Am Chem Soc1964，86，8： | 1 |
| 4 | Cytokine production in the brain following the closed head injury:dexanabinol (Hu-211) is a novel TNF inhibitor and an effective neuroprotectaut显示文摘 | Shohami E Gallily R Mechoulam R | 1997 | J Neuroimmunol1997，72，2： | 1 |
| 5 | Cannabidiol:an oveview of some pharmacological aspects显示文摘 | Mechoulam R Parker L A Gallily R | 2002 | J Clin Pharmacol2002，42，11： | 1 |
| 6 | Boswellia resin:from religious ceremonies to medical uses:a review of in-vitro,in-vivo and clinical trials显示文摘 | Moussaieff A Mechoulam R | 2009 | J Pharm Pharmacol2009，61，10： | 1 |
| 7 | Identification of an endogenous 2-monoglyceride,present in canine gut,that binds to cannabinoid receptors显示文摘 | Mechoulam R Ben-Shabat S Hanus L | 1995 | Biochem Pharmacol1995，50，1： | 1 |
| 8 | Endocannab-inoids and neumprotection显示文摘 | MECHOULAM R SPATZ M SHOHAIILI E | 2002 | Sci STKE2002，，129： | 1 |
| 9 | Endocannabinoids显示文摘 | Mechoulam R Fride E Di Marzo V | 1998 | Eur J Pharmacol1998，359，1： | 1 |
| 10 | Dexanabinol ( HU-211 ) : a nonpsychotropic cannabinoid with neuroprotetive properties显示文摘 | Shohami E Mechoulam R | 2000 | Drug Dev Res2000，50，： | 1 |
| 11 | Identification of an endogenous 2-monoglyceride,present in canine gut,that binds to cannabinoid receptors显示文摘 | Mechoulam R Ben-Shabat S Hanu L | 1995 | Biochemical Pharmacology1995，，01： | 1 |
| 12 | Endocannabi- holds显示文摘 | MECHOULAM R FRIDE E MARZO DV | 1998 | Eur J Pharmacol1998，359，1： | 1 |
| 13 | Expression and activation of STAT3 in ischemia-induced retinopathy显示文摘 | Mechoulam H Pierce EA | 2005 | Invest Ophthalmol Vis Sci2005，46，12： | 1 |
| 14 | Cannabidiol-recent advances显示文摘 | Mechoulam R Peters M Murillo-Rodriguez E | 2007 | Chem Biodivers2007，4，8： | 1 |
| 15 | Identifica- tion of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors 显示文摘 | Mechoulam R Ben-Shabat S Hanus L | 1995 | BiochemPharmacol1995，50，1： | 1 |
| 16 | Endocannabinoids and neuroprotection显示文摘 | Mechoulam R Spatz M Shohami E | 2002 | Sci STKE2002，2002，129： | 1 |
| 17 | The CB1 cannabi- noid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats 显示文摘 | Gilgun-Sherki Y Melamed E Mechoulam R | 2003 | Pharmacol Toxicol2003，93，： | 1 |
| 18 | Endocannabinoids 显示文摘 | Mechoulam R Fride E Marxo V D | 1998 | Eur J Phamacol1998，359，1： | 1 |
| 19 | Cytokine production in the brain following closed head injury:dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant显示文摘 | Shohami E Gallily R Mechoulam R | | 0，，： | 1 |
| 20 | Tetrahydrocannabinol and en- docannabinlids in feeding and appetite 显示文摘 | Berry E M Mechoulam R | 2002 | Pharmacol Ther2002，95，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员